Abstract:AIM: To investigate the underlying mechanisms of xanthohumol (XN) on the proliferation inhibition and death of C6 glioma cells. METHODS: To determine the effects of XN on C6 cells, cell proliferation and mortality after XN treatment were assessed by SRB assay and trypan blue assay respectively. Apoptotic rates were evaluated by flowcytometry after Annexin V-FITC/PI double staining. The influence of XN on the activity of caspase-3 was determined by Western blot (WB); and nuclear transposition of apoptosis-inducing factor (AIF) was tested by immunocytochemistry and WB. By MitoSOXTM staining, the mitochondrial ROS were detected. Mitochondrial function was also tested by MTT assay (content of succinic dehydrogenase), flow cytometry (mitochondrial membrane potential (MMP)—JC-1 staining; mitochondrial abundance—mito-Tracker green), immunofluorescence (MMP—JC-1 staining; mitochondrial morphology—mito-Tracker green), WB (mitochondrial fusion-fission protein—OPA1, mfn2, and DRP1; mitophagy-related proteins—Pink1, Parkin, LC3B, and P62), and high-performance liquid chromatography (HPLC) (energy charge). Finally, mitochondrial protein homeostasis of C6 cells after XN treatment with and without LONP1 inhibitor bortezomib was investigated by trypan blue assay (proliferative activity and mortality) and WB (mitochondrial protease LONP1). All cell morphology images were taken by a Leica Microsystems microscope. RESULTS: XN could lead to proliferation inhibition and death of C6 cells in a time- and dose-dependent manner and induce apoptosis of C6 cells through the AIF pathway. After long incubation of XN, mitochondria of C6 cells were seriously impaired, and mitochondria had a diffuse morphology and mitochondrial ROS were increased. The content of succinic dehydrogenase per cell was significantly decreased after XN insults of 24, 48, and 72 h. The energy charge was weakened after XN insult of 24 h. Furthermore, the MMP and mitochondrial abundance were significantly decreased; the protein expression levels of OPA1, mfn2, and DRP1 were down-regulated; and the protein expression levels of Pink1, Parkin, LC3B-II/LC3B-I, and p62 were up-regulated in long XN incubation times (24, 48, and 72 h). XN incubation with bortezomib for 48 h resulted in lower proliferative activity and higher mortality of C6 cells and caused the cell to have visible vacuoles. Moreover, the protein expression levels of LONP1 was up-regulated gradually as XN treatment time increased. CONCLUSION: These data supported that XN could induce AIF pathway apoptosis of the rat glioma C6 cells by affecting the mitochondria.

NADPH Treatment Induces Profound Necrosis of C6 Glioma Cells

Nadh Can Induce Necrosis of C6 Glioma Cells and Neuro2a Cells

NAD+ Treatment Induces Tumor Cell Necrosis by P2X7 Receptor‐Independent Pathways

Nad+ Induces C6 Glioma Cell Death by Generating Oxidative Stress and Increasing Intracellular Calcium Concentrations

NAD+ Treatment Decreases Tumor Cell Survival by Inducing Oxidative Stress.

Modulation of G6PD Affects Bladder Cancer Via ROS Accumulation and the AKT Pathway in Vitro.

Oxidative Stress and PARP Activation Mediate the NADH-induced Decrease in Glioma Cell Survival.

Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions

Delayed Treatment of NAD+ Can Restore Intracellular ATP Levels and Prevent PC12 Cell Death Induced by Oxidative Stress

Unexpected Photocatalytic Degeneration of NAD + for Inducing Apoptosis of Hypoxia Cancer Cells

NAD+ Treatment Can Block Rotenone‐induced Nuclear Apoptotic Changes of PC12 Cells

NAD+ Induces Autophagy of Neuro2a Cells by Increasing Oxidative Stress

NAD+ Treatment Can Prevent Multiple Rotenone‐induced Apoptotic Changes of PC12 Cells

Xanthohumol-Induced Rat Glioma C6 Cells Death by Triggering Mitochondrial Stress

Nicotinamide Phosphoribosyltransferase Inhibitor APO866 Induces C6 Glioblastoma Cell Death Via Autophagy.

NAD+ Treatment Can Prevent Rotenone-Induced Increases in DNA Damage, Bax Levels and Nuclear Translocation of Apoptosis-Inducing Factor in Differentiated PC12 Cells

Targeting Glucose-6-phosphate Dehydrogenase by 6-AN Induces ROS-mediated Autophagic Cell Death in Breast Cancer

Roles of NAD(+) / NADH and NADP(+) / NADPH in Cell Death.

NAD+ Treatment Induces Delayed Autophagy in Neuro2a Cells Partially by Increasing Oxidative Stress

Effect of HpD-PDT on cultured Rat C6 Glioma Cells

NAD+ depletion radiosensitizes 2-DG-treated glioma cells by abolishing metabolic adaptation